Journal of Diabetes and Its Complications

Article	Citations
Contents/Barcode	55
Individual and joint effects of diabetes and depression on incident cardiovascular diseases and all-cause mortality: Results from a population-based cohort study	54
The association between age at diagnosis of diabetes and development of diabetic retinopathy and assessment of healthcare access as an effect modifier	50
Prognostic value of insulin resistance and hyperglycemia biomarkers for long-term risks of cardiometabolic outcomes	48
Confirmatory factor analysis including MRI-derived adipose tissues quantification improves associations of metabolic dysregulation to diastolic dysfunction	46
Protective effect of evolocumab on Müller cells in the rat retina under hyperglycaemic and hypoxic conditions	45
Effect of fixed-dose combination of insulin degludec and liraglutide on apoB-containing lipoprotein subclasses and HDL lipidome in type 2 diabetes	44
Changes in cardiac and vascular haemodynamics as potential mediators of improvements in cardiovascular and kidney outcomes with empagliflozin in type 2 diabetes	42
Assessing the influence of rural residence and economic distress on lower extremity risk stratification among diabetic foot ulcer patients utilizing the Wound, Ischemia, and Foot Infection (WIfI) clas	39
Fatty acid synthase (Fasn) inhibits the expression levels of immune response genes via alteration of alternative splicing in islet cells	37
Time to develop chronic kidney disease in an Ecuadorian Type 2 Diabetes Mellitus cohort: Survival analysis in primary care	37
Comparative analysis of the therapeutic effects of pregabalin, gabapentin, and duloxetine in diabetic peripheral neuropathy: A retrospective study	36
Is subclinical cardiovascular disease linked with periodontal disease in diabetic and non-diabetic subjects?	35
The epidemiology of ketosis and low bicarbonate concentration in inpatients treated with sodium-glucose linked cotransporter inhibitors or dipeptidyl peptidase-4 inhibitors	34
Contents/Barcode	30
Effect of new glucose-lowering drugs on stroke in patients with type 2 diabetes: A systematic review and Meta-analysis	28
Echocardiographic evaluation of the effect of dapagliflozin on epicardial adipose tissue and left ventricular systolic function in type 2 diabetes mellitus	28
Association between visit-to-visit variability of glycated albumin and diabetic retinopathy among patients with type 2 diabetes – A prospective cohort study	28
Impact of dronedarone on patients with atrial fibrillation and diabetes: A sub-analysis of the ATHENA and EURIDIS/ADONIS studies	27
Association of continuous subcutaneous insulin therapy and diabetic retinopathy in type 1 diabetes: A national cohort study	27
Corrigendum to “The PanGut-study: Evoked potentials following rectal balloon distention, a way of evaluating diabetic autonomic neuropathy in the gut?” [J. Diabetes Complicat., Volume 37, Issue 5, May	27
Is HbA1c in the first trimester associated with adverse outcomes among pregnant Asian Indian women without gestational diabetes?	27
Effects of moderate-intensity aerobic training on cardiac structure and function in type 2 mellitus diabetic rats: Based on echocardiography and speckle tracking	26
Multidisciplinary management of diabetic foot infection associated with improved 8-year overall survival	26
Relation of coronary calcium scoring with cardiovascular events in patients with diabetes: The CLARIFY Registry	25

Accuracy of a breath ketone analyzer to detect ketosis in adults and children with type 1 diabetes	24
The correlation between patients with type 2 diabetes mellitus and chronic microvascular complications during the glucose peak time	23
Contents/Barcode	23
Non-alcoholic fatty liver disease and sarcopenia is associated with the risk of albuminuria independent of insulin resistance, and obesity	23
Effect of the first and second COVID-19 associated lockdown on the metabolic control of patients with type 2 diabetes in Greece	22
The association between birth weight, ponderal index, psychotropic medication, and type 2 diabetes in individuals with severe mental illness	21
Growth differentiation factor-15: A marker for diabetic kidney disease in patients with metabolic-associated fatty liver disease	21
The effects of SGLT2 inhibitors and GLP-1 receptor agonists on the triglyceride to HDL cholesterol ratio and the triglyceride-glucose index in patients with type 2 diabetes	21
Effect of dapagliflozin on liver and pancreatic fat in patients with type 2 diabetes and non-alcoholic fatty liver disease	19
Editorial commentary to manuscript “Neural correlates of slower gait in middle-aged persons with childhood-onset type 1 diabetes mellitus: The impact of accelerated brain aging” by Royse et al	19
Comment: Type 1 diabetes and oral health: Findings from the Epidemiology of Diabetes Interventions and Complications (EDIC) study	19
Serum Isthmin-1 is negatively correlated with HDL-C in type 2 diabetes mellitus	18
Association between first-line monotherapy with metformin and the risk of atrial fibrillation (AMRAF) in patients with type 2 diabetes	18
Factors associated with adherence or nonadherence to insulin therapy among adults with type 2 diabetes mellitus: A scoping review	18
Association of insomnia with incident chronic cognitive impairment in older adults with type 2 diabetes mellitus: A prospective study of the Hong Kong Diabetes Register	18
Contents/Barcode	18
Inflammation level in type 2 diabetes is associated with dietary advanced glycation end products, Mediterranean diet adherence and oxidative balance score: A pathway analysis	17
Cytokine gene variants of TNF-α and IL-10 in the propensity of type 2 diabetes in south Indian population	17
Circulating soluble CD163 as a potential biomarker of diabetes complications	16
Highlighting the complex relationship between diabetes, renal function and bone health	16
Elastographic parameters of liver steatosis and fibrosis predict independently the risk of incident chronic kidney disease and acute myocardial infarction in patients with type 2 diabetes mellitus	16
Methylglyoxal induces death in human brain neuronal cells (SH-SY5Y), prevented by metformin and dapagliflozin	16
Diabetes and the treatment of ischemic stroke	15
Cumulative incidence of and risk factors for herpes zoster among patients with diabetes mellitus: Results from a 10-year nested case-control study	15
Sleep quality and heart rate variability in adolescents with type 1 or type 2 diabetes	15
Semaglutide, central retinal thickness and continuous glucose monitoring in persons with type 2 diabetes: A post-hoc analysis from a randomised trial	15
Changes in the prognostic values of modern cardiovascular biomarkers in relation to duration of diabetes mellitus	15
Reduced skeletal muscle mass to visceral fat area ratio is independently associated with reduced cognitive function in type 2 diabetes mellitus	14
Symptomatic diabetic autonomic neuropathy in type 1 diabetes (T1D): Findings from the T1D exchange	14
The effect of dapagliflozin therapy on ventricular repolarization parameters in electrocardiography in patients with diabetic cardiovascular disease	14
A comparison of the ratios of C-reactive protein and triglycerides to high-density lipoprotein-cholesterol as biomarkers of metabolic syndrome in African Americans and non-Hispanic Whites	14
Health status in stage B heart failure from diabetic cardiomyopathy baseline results from ARISE-HF	14
Outcomes associated with a variable rate insulin infusion diabetic ketoacidosis protocol	13
Single and joint impact of type 2 diabetes and of congestive heart failure on albuminuria	13
The PanGut-study: Evoked potentials following rectal balloon distention, a way of evaluating diabetic autonomic neuropathy in the gut?	13
Disordered glycemic control in women with type 2 diabetes is associated with increased TNF receptor-2 levels	13
Stepwise cardiovascular risk stratification in patients with type 2 diabetes based on coronary CT assessment	12
Clinical features and outcomes of patients diagnosed with diabetic ketoacidosis (DKA) who were hospitalized for conditions outside of internal medicine	12
Contents/Barcode	12
Role of profilin-1 in vasculopathy induced by advanced glycation end products (AGEs)	12
Inhibition of IL-33 signaling ameliorate hepatic fibrosis with decreasing MCP-1 in a mouse model of diabetes and non-alcoholic steatohepatitis; comparison for luseogliflozin, an SGLT2 inhibitor	12
Impact of SGLT2 inhibitors on the mechanisms of myocardial dysfunction in type 2 diabetes: A prospective non-randomized observational study in patients with type 2 diabetes mellitus without overt hear	12
Transient albuminuria in the setting of short-term severe hyperglycemia in type 1 diabetes	12
Lower extremity amputation rates in patients with chronic kidney disease: A database study comparing patients with and without diabetes mellitus	12
Von Willebrand factor hyperactivity affects the outcome of lower limb revascularization in subjects with type 2 diabetes mellitus complicated by diabetic foot vasculopathy: An observational pilot stud	12
Effects of semaglutide and empagliflozin on oxygenation, vascular autoregulation, and central thickness of the retina in people with type 2 diabetes: A prespecified secondary analysis of a randomised	11
The effect of bariatric surgery on diabetes related foot complications among patients with type 2 diabetes: A systematic review	11
Achievement of low-density lipoprotein cholesterol goals in patients with diabetes-related foot ulceration	11
The effect of SGLT2 inhibitors, GLP1 agonists, and their sequential combination on cardiometabolic parameters: A randomized, prospective, intervention study	11
The association between physical activity time and neuropathy in longstanding type 1 diabetes: A cross-sectional analysis of the Canadian study of longevity in type 1 diabetes	11

Contemporary prevalence of diabetic neuropathies in individuals with type 1 and type 2 diabetes in a Danish tertiary outpatient clinic	11
Associations of peroxisome proliferator-activated receptor-γ Pro12Ala polymorphism with non-alcoholic fatty liver disease: A meta-analysis	11
Effects of moderate-intensity resistance exercise on blood glucose and pregnancy outcome in patients with gestational diabetes mellitus: A randomized controlled trial	11
Contents/Barcode	11
Effectiveness of adding glucagon-like peptide-1 receptor agonist on diabetes complications and mortality among basal insulin-treated people with type 2 diabetes: A real-world Korean study	11
PINK1 and oxidative stress in lean and obese patients with type 2 diabetes mellitus	11
Diabetic neuropathy in adolescents and young adults: The need for early detection and improved understanding	11
Implementation of evidence-based foot screening in people with diabetes: A scoping review	11
Systemic and ocular outcomes in patients with young-onset type 2 diabetes	11
The association of glucose control on in-hospital mortality in the cardiac intensive care unit	10
Diabetic ketosis vs ketoacidosis as initial presentation of pediatric type 1 diabetes mellitus. Associated features and rate of progression during the first two years after diagnosis	10
Associations of three diagnostic glycemic measures with all-cause and cardiovascular mortality in people not on antidiabetic medications: A prospective cohort study	10
Temporal trends in non-traumatic lower extremity amputations (LEAs) and their association with 12-month mortality in people with diabetes, 2004–2016	10
Increased intracellular miR-142 in adults with Type 1 diabetes	10
Achievement of treatment targets predicts progression of vascular complications in type 1 diabetes	10
Level of physical activity and gene expression of IL-10 and TNF-α in children and adolescents with Type 1 diabetes	9
High fat-induced the upregulation of LOX-1 in RF/6A cells under high glucose condition	9
The legacy effect in early-stage diabetes: Don't stay by me, cardiovascular disease!	9
Body-weight functional exercise promotes greater and safer blood glucose reduction compared to aerobic and strength exercises in type 1 diabetics: a randomised crossover study	9
Correlation of cerebral small vessel disease burden with outcome after lower extremity amputation	9
Prevalence of cardiovascular and renal comorbidities among patients with type 2 diabetes routinely treated in the primary care setting in Greece: An epidemiological study (the RECARDIA study)	9
Adults with type 2 diabetes benefit from self-management support intervention regardless of depressive symptoms	9
Protein kinase C: A potential therapeutic target for endothelial dysfunction in diabetes	8
Diabetes mellitus therapy in the light of oxidative stress and cardiovascular complications	8
Unmet needs and opportunities for optimal management of patients with type 2 diabetes and chronic kidney disease	8
The effect of vitamin D supplementation on cardiovascular risk in patients with prediabetes: A secondary analysis of the D2d study	8
Frequency and association of self-reported oral cancer among individuals with type 2 diabetes at a tertiary care diabetes centre in South India - A retrospective study	8
Contents/Barcode	8
Association of mid-life cerebral small vessel disease with diabetic retinopathy in type 2 diabetes in an Indian population	8
Whole-body insulin clearance in people with type 2 diabetes and normal kidney function: Relationship with glomerular filtration rate, renal plasma flow, and insulin sensitivity	8
Time in range is associated with less hypoglycemia fear and higher diabetes technology acceptance in adults with well-controlled T1D	8
Prognostic importance of baseline and changes in serum uric acid for macro/microvascular and mortality outcomes in individuals with type 2 diabetes: The Rio de Janeiro type 2 diabetes cohort	8
From obesity to Alzheimer's disease through insulin resistance	8
Understanding the mechanisms mediating cardio-renal benefit of empagliflozin in type 2 diabetes mellitus	8
Association between extrapolated time in range and large for gestational age infants in pregnant women with type 1 diabetes	8
Effects of probiotics and fibers on markers of nephropathy, inflammation, intestinal barrier dysfunction and endothelial dysfunction in individuals with type 1 diabetes and albuminuria. The ProFOS Stu	8
Serum visfatin levels are positively correlated with dietary carbohydrate and polyunsaturated fatty acid intakes in type 2 diabetes mellitus patients	8
Beyond pounds: What else could be lost?	8
Contents/Barcode	8
The anti-inflammatory agent 5-ASA reduces the level of specific tsRNAs in sperm cells of high-fat fed C57BL/6J mouse sires and improves glucose tolerance in female offspring	8
Relationship between adiponectin and muscle mass in patients with metabolic syndrome and obesity	8
Development of clinical prediction models for renal and cardiovascular outcomes and mortality in patients with type 2 diabetes and chronic kidney disease using time-varying predictors	8
Disease-modifying therapies for diabetic peripheral neuropathy: A systematic review and meta-analysis of randomized controlled trials	8
Design and rationale of DISCOVER global registry in type 2 diabetes: Real-world insights of treatment patterns and its relationship with cardiovascular, renal, and metabolic multimorbidities	8
Contents/Barcode	8
Association between Mediterranean diet adherence and peripheral artery disease in type 2 diabetes mellitus: An observational study	8
Urinary A- and C-megalin predict progression of diabetic kidney disease: an exploratory retrospective cohort study	8
Pioglitazone increases risk of ischemic heart disease in patients with type 2 diabetes receiving insulin	8
Diagnosis, management and impact of painful diabetic peripheral neuropathy: A patient survey in four European countries	7
Relationship between elevated microRNAs and growth factors levels in the vitreous of patients with proliferative diabetic retinopathy	7
Muscle mitochondrial function is impaired in adults with type 1 diabetes	7
Long-term effects of l-serine supplementation upon a mouse model of diabetic neuropathy	7
Impact of Glucagon-like peptide 1 receptor agonists on peripheral arterial disease in people with diabetes mellitus: A narrative review	7
Progress in the treatment of vascular complications in type 2 diabetes by finerenone in combination with RAS inhibitors/SGLT-2i	7
Altered RBC membrane lipidome: A possible etiopathogenic link for the microvascular impairment in Type 2 diabetes	7
Contents/Barcode	7
Cardiovascular events after a dramatic reduction of HbA1c in hospitalized subjects with type 2 diabetes and high long-term glucose exposure	7
Age different effects of SGLT2 inhibitors on body composition in individuals with type 2 diabetes: A retrospective cohort study	7
Contents/Barcode	7
Effect of prior gestational diabetes on the risk of cardiovascular disease and death in women with type 2 diabetes: The Fremantle Diabetes Study Phase II	7
Gestational diabetes mellitus and hypertensive disorder of pregnancy play as spouse-pair risk factors of diabetes and hypertension: Insights from Tehran Lipid and Glucose Study	7
Predictors of liver fibrosis progression in cohort of type 2 diabetes mellitus patients with MASLD	7
Kidney fat by magnetic resonance spectroscopy in type 2 diabetes with chronic kidney disease	7
Efficacy and safety of sodium glucose cotransporter 2 inhibitors plus standard care in diabetic kidney disease: A systematic review and meta-analysis	7
Influence of type 2 diabetes mellitus on mortality in women with breast cancer: A matched case-control study	7
Type 2 diabetes mellitus in obesity promotes prolongation of cardiomyocyte contractile function, impaired Ca2+ handling and protein carbonylation damage	7
The handgrip test – A historical test for diabetic autonomic neuropathy or a marker of something else?	7
Fatty acid binding protein 1 (FABP1) and fatty acid binding protein 2 (FABP2) as a link between diabetic nephropathy and subclinical atherosclerosis in children and adolescents with type 1 diabetes	7
All-cause mortality and factors associated with it in Finnish patients with type 1 diabetes	7
Urogenital side effects in male subjects with type 2 diabetes treated with SGLT-2 inhibitors: A single centre, longitudinal observation	7
Slowly progressive subtype of childhood-onset type 1 diabetes as a high-risk factor for end-stage renal disease: A cohort study in Japan	7
Contents/Barcode	7
Predicting the occurrence of DKA following sodium glucose co-transporter-2 inhibitors: An international cohort study	7
Gender difference in association between diabetes mellitus and all-cause mortality in atrial fibrillation patients	7
Type 1 diabetes and oral health: Findings from the Epidemiology of Diabetes Interventions and Complications (EDIC) study	7
A comparative study of the relationship between time in range assessed by self-monitoring of blood glucose and continuous glucose monitoring with microalbuminuria outcome, HOMA-IR and HOMA-β test	7
Comparison of two-year clinical outcomes according to glycemic status and renal function in patients with acute myocardial infarction following implantation of new-generation drug-eluting stents	7
Examining the effects of the CLU and APOE polymorphisms' combination on coronary artery disease complexed with type 2 diabetes mellitus	7
Characterizing the relationship between social determinants of health and risk of albuminuria among children with type 1 diabetes	7
Variation in the hemoglobin glycation index	7

Uric acid in diabetic microvascular complications: Mechanisms and therapy	7
The role of circRNA in insulin resistance and its progression induced by adipose inflammation	7
Tobacco use patterns and clinical outcomes in the T1D exchange	7
Angiogenic potential of mesenchymal stem cells derived from patients with diabetes seeded on decellularized micro fragments	7
The association of insulin responses and insulin sensitivity with cognition in adults with pre-diabetes: The Diabetes Prevention Program Outcomes Study	7
Differential effects of treatment targets on risks of adverse outcomes according to diabetes duration, age and complications: Can these characteristics be used to individualize diabetes treatment? The	6
Risk factors at admission of in-hospital dysglycemia, mortality, and readmissions in patients with type 2 diabetes and pneumonia	6
The glycemic status determines the direction of the relationship between red cell distribution width and HbA1c	6
Randomized comparison of self-monitored blood glucose (BGM) versus continuous glucose monitoring (CGM) data to optimize glucose control in type 2 diabetes	6
GLP-1 and dual GIP/GLP-1 receptor agonists in overweight/obese patients for atherosclerotic cardiovascular disease prevention: Where are we now?	6
Impact of visit-to-visit glycated hemoglobin variability on diabetes distress and its subscales	6
Metformin in m.3243A>G carriers can be both detrimental and beneficial	6
Circulating CD31+ Angiogenic T cells are reduced in prediabetes and increase with exercise training	6
Duration of diabetes, glycemic control, and low heart rate variability: The Atherosclerosis Risk in Communities (ARIC) study	6
Covid-19: A new cause of “provoked” A-β+ Ketosis-Prone Diabetes	6
Obesity and glycemic control among people with type 2 diabetes in the United States: A retrospective cohort study using insurance claims data	6
The role of atherogenic lipoproteins in diabetes: Molecular aspects and clinical significance	6
Increased skeletal muscle mass index was involved in glycemic efficacy following diabetes treatment, and changes in fat mass index correlated with the changes in the lipid ratio in type 2 diabetes	6
Left ventricular longitudinal systolic dysfunction in children with type 1 diabetes mellitus: A systematic review and meta-analysis	6
Association of FTO, ABCA1, ADRB3, and PPARG variants with obesity, type 2 diabetes, and metabolic syndrome in a Northwest Mexican adult population	6
Bone mineral density and the risk of kidney disease in patients with type 1 diabetes	6
How to evaluate over 60 million blood glucose data — The design of the MÉRY Diabetes Database	6
Increase in hypoglycaemia and hyperglycaemia in people with diabetes admitted to hospital during COVID-19 pandemic	6
Contents/Barcode	6
Cost effectiveness of topical wound oxygen therapy for chronic diabetic foot ulcers	6
The effect of continuous glucose monitoring-guided glycemic control on progression of coronary atherosclerosis in type 2 diabetic patients with coronary artery disease: The OPTIMAL randomized clinical	6
Soluble urokinase plasminogen activator receptor, platelet aggregation, and carotid plaque thickness in diabetes: A cross-sectional analysis	6
“It changed everything we do”: A mixed methods study of youth and parent experiences with a pilot exercise education intervention following new diagnosis of type 1 diabetes	6
Association of peripheral neuropathy with subclinical left ventricular dysfunction in patients with type 2 diabetes	6
Obesity and its management in primary care setting	6
Long term risk of heart failure in individuals with childhood-onset type 1 diabetes	6
Analysis of the therapeutic potential of miR-124 and miR-16 in non-alcoholic fatty liver disease	6